Search Results - "Puc, H S"

Management of residual mass in advanced seminoma: results and recommendations from the Memorial Sloan-Kettering Cancer Center by Puc, H S, Heelan, R, Mazumdar, M, Herr, H, Scheinfeld, J, Vlamis, V, Bajorin, D F, Bosl, G J, Mencel, P, Motzer, R J

“…Guidelines for management of postchemotherapy residual mass in patients with advanced seminoma remain controversial. We sought to characterize independent…”
Get more information

Surgery for a post-chemotherapy residual mass in seminoma by Herr, H W, Sheinfeld, J, Puc, H S, Heelan, R, Bajorin, D F, Mencel, P, Bosl, G J, Motzer, R J

“…We attempted to select patients for surgery of post-chemotherapy residual mass in advanced seminoma. A total of 55 patients with advanced seminoma underwent…”
Get more information

Phase II trial of topotecan in patients with cisplatin-refractory germ cell tumors by HEIDI SONYA PUC, BAJORIN, D. F, BOSL, G. J, AMSTERDAM, A, MOTZER, R. J

“…Fifteen patients with advanced, cisplatin-refractory germ cell tumors (GCT) were treated on a phase II trial with topotecan. None of the 14 evaluable patients…”
Get full text

Diamond-Like Carbon Coating and Plasma or Glow Discharge Treatment of Mechanical Heart Valves by Tran, H S, Puc, M M, Hewitt, C W, Soll, D B, Marra, S W, Simonetti, V A, Cilley, J H, DelRossi, A J

“…All mechanical heart valves (MHV) are thrombogenic. Application of surface modification technology to reduce the incidence of thrombus formation on MHV is a…”
Get full text